Well, it turns out cf33 (+cd19) really might be the keys to the kingdom, based on these three abstracts.
IMU's point with these abstracts is that oncarlytics can indeed facilitate killing solid tumor. Although not in humans yet, all three abstracts seem to be collectively saying that three completely different technologies all killed solid tumors through oncarlytics using the cd19 pathway. Oncarlytics was the key to unlock this ability for all the various cd19 targeted technologies here.
It's seems like oncarlytics is a longhaul trucking business connecting suppliers and customers, but IMU are the only company in the world with trucks. All the Trucking magnates in Aus will be salivating.
IMV, that is resounding at this stage of the science.
Hopefully we get a BP partner/deal with this.
Good luck all.
Ann: onCARlytics to be showcased in three abstracts at SITC, page-55
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |